Majispa tablets combine Drotaverine Hydrochloride 80mg and Mefenamic Acid 250mg in each film-coated tablet, delivering comprehensive relief from pain and muscle spasms. This pharma...

Majispa tablets combine Drotaverine Hydrochloride 80mg and Mefenamic Acid 250mg in each film-coated tablet, delivering comprehensive relief from pain and muscle spasms. This pharmaceutical product is manufactured under rigorous quality control standards, guaranteeing consistent dosage and reliable therapeutic performance. The smooth film coating facilitates easier swallowing and protects the active ingredients, making it suitable for patients requiring prompt and effective intervention. Healthcare providers trust Majispa for its balanced formulation that simultaneously addresses pain perception and smooth muscle contractions, offering complete treatment in a single, convenient tablet.

This medication serves extensive applications across multiple medical specialties including gynecology, surgery, general medicine, and emergency care. Hospitals and clinical facilities utilize Majispa for managing dysmenorrhea, postoperative pain, abdominal cramps, and various musculoskeletal conditions. Pharmaceutical distributors and wholesalers supply this product to retail pharmacies, healthcare institutions, and medical stores serving patients with acute pain requirements. The product's proven reliability makes it a fundamental component in medical inventories across diverse healthcare environments, from urban medical centers to rural healthcare facilities.

Organizations selecting Majispa benefit from its demonstrated efficacy, quality assurance, and consistent performance that meets specific therapeutic needs. The product's unique dual-component formulation distinguishes it from single-ingredient alternatives, providing enhanced value to distributors and healthcare providers. Its reliability ensures repeat orders and customer satisfaction, while the practical pack of 10 tablets offers convenient inventory management and dispensing efficiency. This combination therapy represents a strategic choice for businesses seeking pharmaceutical products with established clinical effectiveness and consistent market demand.

Key Features:
- Precise dual formulation: 80mg Drotaverine Hydrochloride and 250mg Mefenamic Acid per tablet
- Smooth film coating for easier swallowing and enhanced patient compliance
- Manufactured under strict quality control protocols ensuring consistency and safety
- Convenient pack of 10 tablets for efficient dispensing and inventory management
- Reliable performance backed by clinical validation and medical trust

Benefits:
- Comprehensive relief from both pain and muscle spasms in single tablet
- Improved patient comfort and treatment adherence through film-coated design
- Consistent quality and dosage accuracy for predictable therapeutic outcomes
- Efficient inventory management and dispensing with practical packaging
- Trusted solution preferred by healthcare professionals across multiple specialties